Document and Entity Information
Document and Entity Information | May 10, 2023 |
Cover [Abstract] | |
Entity Registrant Name | NGM BIOPHARMACEUTICALS INC |
Amendment Flag | false |
Entity Central Index Key | 0001426332 |
Document Type | 8-K |
Document Period End Date | May 10, 2023 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38853 |
Entity Tax Identification Number | 26-1679911 |
Entity Address, Address Line One | 333 Oyster Point Boulevard |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | (650) |
Local Phone Number | 243-5555 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | NGM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |